thiazoles has been researched along with srt1720 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, Y; Kobayashi, Y; Matsuya, Y; Miyata, N; Sawada, H; Sugimoto, K; Suzuki, T; Toyooka, N; Uchida, S | 1 |
| Billadeau, DD; Chini, CC; Chini, EN; Escande, C; Espindola-Netto, JM; Guerrico, AM; Mondal, G; Nin, V; Sola-Penna, M; Zhang, JS | 1 |
2 other study(ies) available for thiazoles and srt1720
| Article | Year |
|---|---|
Search for a novel SIRT1 activator: structural modification of SRT1720 and biological evaluation.
Topics: Enzyme Activation; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Docking Simulation; Sirtuin 1; Thiazoles | 2013 |
SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway.
Topics: Anilides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Female; Gemcitabine; Heterocyclic Compounds, 4 or More Rings; Humans; Lysosomes; Mice; Mice, Nude; Paclitaxel; Pancreatic Neoplasms; Sirtuin 1; Thiazoles | 2016 |